Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study

Bibliographic Details
Title: Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study
Authors: Chase, Dana 1, *, Huang, Helen Q 2, Monk, Bradley J 3, Ramondetta, Lois Michelle 4, Penson, Richard T 5, Gil, Karen 6, Landrum, Lisa M 7, Leitao, Mario 8, Oaknin, Ana 9, Huh, Warner K 10, Pulaski, Heather L 11, Robison, Katina 12, Guntupalli, Saketh R 13, Richardson, Debra 14, Salani, Ritu 15, Sill, Michael W 2, Wenzel, Lari B 16, Tewari, Krishnansu Sujata 17
Source: In International Journal of Gynecological Cancer May 2020 30(5):596-601
Database: ScienceDirect
More Details
ISSN:1048891X
DOI:10.1136/ijgc-2019-000869
Published in:International Journal of Gynecological Cancer
Language:English